Targeting the cell cycle for cancer therapy
2002
Targeting the Cell Cycle for Cancer Therapy
publication
Evidence: moderate
Author Information
Author(s): Carnero A
Primary Institution: Centro Nacional de Investigaciones Oncologicas (CNIO)
Hypothesis
Targeting the regulatory molecules of the cell cycle, specifically cyclin-dependent kinases, can lead to the development of new anticancer drugs.
Conclusion
The study suggests that targeting the cell cycle may provide a promising avenue for developing new anticancer therapies.
Supporting Evidence
- Most cancers have problems with how their cells divide.
- New drugs targeting the cell cycle are being tested and show promise.
- Some compounds have already entered clinical trials with good results.
Takeaway
Scientists are trying to find new ways to treat cancer by focusing on how cells divide. They think that by stopping certain parts of this process, they can make new medicines to help people with cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website